Stocks

S&P/ASX 200 Index (ASX: XJO) shares are in the green today as we review some expert views and ratings on NextDC Ltd (ASX: NXT) and 2 others.

Biotechnology company Spyre Therapeutics said it has priced its underwritten public offering of 4,117,648 shares of common stock at $85.00 per share. The company expects gross proceeds of about $350.0 million, before underwriting discounts and offering expenses.

CSL Limited said it has struck a drug-development partnership with Alentis focused on an investigational claudin1-targeting therapy now in a Phase 2 trial for a rare autoimmune kidney disease. CSL will pay US$355 million upfront and fund the planned development program, while the companies would split global profits 55% to CSL and 45% to Alentis if the treatment reaches the market. CSL shares were trading around A$177 on Tuesday, implying a price-to-earnings multiple of just under 20 times FY27 consensus earnings per share of A$8.99, falling to about 17.5 times based on FY29 EPS of A$10.08.

PTC Industries said its Q1FY27 consolidated revenue from operations rose 97.4% year on year to ₹1,918.0 crore. Net profit climbed 466.2% to ₹291.9 crore, while EBITDA increased 180.1% to ₹542.1 crore. Operating cash flow turned positive at ₹442.5 crore, compared with a negative outflow of ₹345.4 crore a year earlier.

The Trump administration has continued to channel large incentives into the nuclear industry, including a newly announced $4.2 billion federal loan to Ohio nuclear plant operator Vistra. Nuclear-related stocks have not rallied on the policy support, with Vistra down 9% year-to-date. Cameco and Brookfield Asset Management are also down 3% and 15% year-to-date, respectively. Investors have appeared unmoved by the announcements, with shares in several cases falling after the incentives were revealed.

AMD said on September 28 it will acquire World Labs in an $8.2 billion all-stock deal. The company aims to strengthen its capabilities in artificial intelligence model research. The transaction is also viewed as a key move to secure AI talent as AMD pushes development of next-generation AI technologies.

Hon Hai Precision Industry (Foxconn), a partner of Nvidia, said third-quarter sales rose 47% year on year to $95.4 billion, beating the market estimate of $89 billion. September revenue climbed 38% from a year earlier to NT$1.16 trillion, marking the company’s first month above NT$1 trillion. Bloomberg Intelligence expects Hon Hai’s revenue and earnings to sustain 25%–35% growth over the next few years, driven by demand for AI infrastructure.

Oracle is set to pay a quarterly dividend of $0.50 per share on October 23, 2026, with the record date approaching. At a share price of $142, the stock implies a forward dividend yield of about 1.41%, or $2 per share annually. The company’s forward payout ratio is 18.15%, leaving significant room to fund expansion. Cloud infrastructure revenue rose 121% year over year to $7.4 billion, while cloud applications revenue increased 10% to $4.2 billion.

Samsung Electronics is expected to post a record third-quarter operating profit of 108.1 trillion won, propelled by a sharp rise in demand for memory semiconductors. Revenue for the same period is projected at about 201.7 trillion won, up 134.4% year on year. The Device Solutions division is forecast to deliver an operating margin of 72% to 75%, underscoring the profitability of the chip business.

SeaStar Medical Holding Corporation (Nasdaq: ICU) entered definitive agreements on October 2, 2026 for the immediate cash exercise of about 854,002 previously issued warrants from June 2025, July 2025 and August 2025. The exercise price was reduced from $6.38 to $7.62 per share to $3.866 per share. The company expects aggregate gross proceeds of approximately $3.3 million, before deducting placement agent fees and other offering expenses.